Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

ATXN2 Gene Spinocerebellar Ataxia Type 2, Autosomal Dominant Genetic Test in UAE | 2,800 AED | DHA Licensed

Executive Summary & Core Metrics

ATXN2 Gene SCA2 NGS Test Overview

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
  • Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
  • Clinical Guidance: Post‑test Telephonic Clinical Guidance for personalised result interpretation by DHA‑licensed experts.
  • Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
ISO 9001:2015 Certified

Facility License: 1143

Test Overview & Methodology

This advanced Next‑Generation Sequencing (NGS) test precisely identifies pathogenic CAG trinucleotide repeat expansions in the ATXN2 gene, confirming a diagnosis of Spinocerebellar Ataxia Type 2 (SCA2). It is ideal for symptomatic patients, at‑risk family members, and individuals seeking proactive neurogenetic insight.

Feature Our Test – SCA2 NGS Closest Alternative
Methodology Next‑Generation Sequencing (NGS) with repeat‑primed PCR confirmation Conventional PCR + fragment analysis (limited multiplex)
Diagnostic Sensitivity 99.9% (detects full range of CAG expansions) ~95% (may miss large expansions)
Turnaround Time 3 to 4 Weeks 4 to 6 Weeks
Genetic Counseling Included – pre‑ and post‑test session Often not included or external referral
Home Collection VIP Mobile Phlebotomy, 8 AM–11 PM Clinic visit only

Physician Insight & Safety Protocols

LG

Lina Osama Zaki Quteineh — DHA License: 9294403 | Consultant Medical Genetics

“As a consultant in medical genetics, I emphasize that this NGS‑based ATXN2 test must be correlated with your detailed neurological examination and family history. A positive result provides a definitive molecular diagnosis and informs personalized management strategies, but genetic testing is only one part of a comprehensive clinical evaluation. Clinical correlation is essential for accurate interpretation.”

Exclusion Criteria & Emergency Red Flags

  • Exclusion: Asymptomatic minors require parental consent and mandatory genetic counselling. If you are taking prescribed medication, never discontinue it without consulting your doctor.
  • Exclusion: Recent hematopoietic stem cell transplant or allogeneic bone marrow transplant may contaminate germline DNA and lead to inaccurate results. Please inform the laboratory.
  • Red Flag – Seek ER Care: Sudden worsening of gait, frequent falls, swallowing difficulty (dysphagia) with choking, or acute speech loss.

Patient FAQ & Clinical Guidance

1. What is the ATXN2 gene test used for?

The ATXN2 gene test detects abnormal CAG repeat expansions causing Spinocerebellar Ataxia Type 2, providing a definitive molecular diagnosis for progressive ataxia and guiding family risk assessment.

2. How is the sample collected?

For standard whole blood, a certified phlebotomist performs a standard blood draw during our VIP Mobile Phlebotomy home collection service. The procedure is quick and minimally uncomfortable.

3. What do positive or negative results indicate?

A positive result confirms SCA2 and supports clinical management, reproductive options, and family screening; a negative result significantly reduces suspicion but does not exclude other ataxias. Your genetics consultant will discuss implications in detail.

UAE Regulatory & Data Privacy Adherence

Data Protection and Legal Compliance

This service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is processed in ISO 9001:2015 certified facilities. Direct billing verification: WhatsApp +971 54 548 8731. DHA Facility License Number: 1143.

Clinical & Logistical Metadata

Attribute Value
Test Name ATXN2 Gene Spinocerebellar Ataxia Type 2, Autosomal Dominant Genetic Test (NGS)
Price (AED) 2,800 AED
Turnaround Time 3 to 4 Weeks
Sample Type / Matrix Whole Blood (Peripheral) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM)
Methodology Used Next-Generation Sequencing (NGS) with Repeat-Primed PCR Confirmation
ICD-10-CM Code G11.8
LOINC Code 38153-2
DHA Facility License & Laboratory Address License Number 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians